[1]姜爱华,李 辉.无偿献血者发生献血不良反应与性别和采血时间的关系[J].医学信息,2020,(11):139-140.[doi:10.3969/j.issn.1006-1959.2020.11.044]
 JIANG Ai-hua,LI Hui.Relationship Between Unpaid Blood Donors’ Adverse Blood Donation Reactions with Gender and Blood Collection Time[J].Medical Information,2020,(11):139-140.[doi:10.3969/j.issn.1006-1959.2020.11.044]
点击复制

无偿献血者发生献血不良反应与性别和采血时间的关系()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2020年11期
页码:
139-140
栏目:
调查分析
出版日期:
2020-06-01

文章信息/Info

Title:
Relationship Between Unpaid Blood Donors’ Adverse Blood Donation Reactions with Gender and Blood Collection Time
文章编号:
1006-1959(2020)11-0139-02
作者:
姜爱华李 辉
(淄博市中心血站,山东 淄博 255000)
Author(s):
JIANG Ai-huaLI Hui
(Zibo City Center Blood Station,Zibo 255000,Shandong,China)
关键词:
无偿献血者不良反应采血时间性别
Keywords:
Unpaid blood donorsAdverse reactionsBlood collection timeGender
分类号:
R193
DOI:
10.3969/j.issn.1006-1959.2020.11.044
文献标志码:
A
摘要:
目的 分析无偿献血者发生献血不良反应与采血时间及性别之间的关系。方法 收集2016年1月~2019年12月于淄博市中心血站行无偿献血的222507例研究对象的资料,根据不同采血时间进行分组,其中8∶00~10∶00采血时间段为A组,10∶00~12∶00采血时间段为B组,12∶00~15∶00采血时间段为C组,15∶00~17∶00采血时间段为D组,分析不同的性别及不同采血时间段发生献血不良反应情况。结果 222507例献血中男性的平均年龄是(35.00±4.71)岁,女性平均年龄(31.00±5.58)岁,差异无统计学意义(P>0.05)。我站无偿献血者献血不良反应的发生率为5.12‰,其中女性献血者献血不良反应发生率(7.42‰)高于男性(4.21‰),差异有统计学意义(P<0.05);B组献血不良反应发生率为9.54‰,高于A组(3.98‰)、C组(4.15‰)及D组(4.13‰),差异有统计学意义(P<0.05)。结论 无偿献血者发生献血不良反应与性别及采血时间相关,因此需对不同性别及不同采血时间献血者采取针对性干预措施,以便减少献血不良反应发生率,保障献血者的安全,利于推动无偿献血工作。
Abstract:
Objective To analyze the relationship between unpaid blood donors’ adverse blood reaction and blood collection time and gender.Methods Collected the data of 222,507 subjects who donated blood at the blood station in Zibo city center from January 2016 to December 2019, and grouped them according to different blood collection times.Among them, the blood collection period from 8∶00 to 10∶00 is group A, the blood collection period from 10∶00 to 12∶00 is group B, and the blood collection period from 12∶00 to 15∶00 is group C,the blood collection period from 15∶00 to 17∶00 was group D, and the adverse reactions of blood donation occurred in different genders and different blood collection periods were analyzed.Results The average age of 222,507 men in blood donation was (35.00±4.71) years old, and the average age of females was (31.00±5.58) years old,there was no significant difference(P>0.05). The incidence of adverse blood donation reactions of unpaid blood donors in our station was 5.12‰, of which the incidence of adverse blood donation reactions of female blood donors(7.42‰) was higher than that of males(4.21‰), the difference was statistically significant(P<0.05); group B blood donation the incidence of adverse reactions was 9.54‰, which was higher than that in group A(3.98‰),group C (4.15‰) and group D(4.13‰), the difference was statistically significant (P<0.05).Conclusion Adverse blood donation reactions of unpaid blood donors are related to gender and blood collection time. Therefore, targeted intervention measures should be taken for blood donors of different genders and different blood collection times in order to reduce the incidence of blood donation adverse reactions, ensure the safety of blood donors, and help promote unpaid blood donation jobs.

参考文献/References:

[1]范亚欣,吴洁玲,孟庆丽,等.全国献血不良反应的调查与分析[J].中国输血杂志,2016,29(9):956-959.[2]GB 18467-2011.献血者健康检查要求[S].北京:中国标准出版社,2012.[3]Tsuno NH,Nagura Y,Kawabata M,et al.The current status of autologous blood transfusion in Japan-the importance of pre-deposit autologous blood donation program and the needs to achieve patient blood management[J].Transfus Apher Sci,2013,49(3):673-680.[4]卞璐.献血不良反应诱因与护理干预研究现状[J].临床血液学杂志(输血与检验),2016,29(2):174-176.[5]孙玉侠,孟宪军.无偿献血不良反应的原因分析与预防[J].临床血液学杂志(输血与检验),2017,30(1):133-135.[6]高朋真.安阳地区献血不良反应的特征及相关因素分析[J].河南医学研究,2019,28(18):3284-3286.

相似文献/References:

[1]董荣长.蓝光治疗新生儿黄疸的效果研究[J].医学信息,2018,(01):116.[doi:10.3969/j.issn.1006-1959.2018.01.044]
 DONG Rong-chang.Study on the Effect of Blue Light in the Treatment of Neonatal Jaundice[J].Medical Information,2018,(11):116.[doi:10.3969/j.issn.1006-1959.2018.01.044]
[2]鲁从林,王先丹,杨遂平,等.奥氮平治疗老年痴呆伴精神行为障碍的临床疗效观察[J].医学信息,2018,(01):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
 LU Cong-lin,WANG Xian-dan,YANG Sui-ping,et al.The Clinical Efficacy of Olanzapine in the Treatment of Alzheimer's Disease with Mental Behavior Disorder[J].Medical Information,2018,(11):138.[doi:10.3969/j.issn.1006-1959.2018.01.053]
[3]邱君旗.幽门螺杆菌根除治疗对幽门螺杆菌阳性的功能性消化不良患者疗效分析[J].医学信息,2018,(04):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
 QIU Jun-qi.Efficacy of Helicobacter Pylori Eradication Therapy in Patients with HP Positive Functional Dyspepsia[J].Medical Information,2018,(11):75.[doi:10.3969/j.issn.1006-1959.2018.04.024]
[4]王国富.舒尼替尼用于治疗晚期肾细胞癌的临床分析[J].医学信息,2018,(06):128.[doi:10.3969/j.issn.1006-1959.2018.06.043]
 WANG Guo-fu.Clinical Analysis of Sunitinib in the Treatment of Advanced Renal Cell Carcinoma[J].Medical Information,2018,(11):128.[doi:10.3969/j.issn.1006-1959.2018.06.043]
[5]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的 临床效果观察[J].医学信息,2018,(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
 LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Medical Information,2018,(11):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[6]孙 阳,秦玉梅.头孢菌素类药物常见不良反应产生原因及护理应用对策研究[J].医学信息,2018,(08):176.[doi:10.3969/j.issn.1006-1959.2018.08.064]
 SUN Yang,QIN Yu-mei.Causes of Common Side Effects of Cephalosporins and Countermeasures for Nursing Application[J].Medical Information,2018,(11):176.[doi:10.3969/j.issn.1006-1959.2018.08.064]
[7]杨 凯.高效抗逆转录病毒治疗艾滋病的临床疗效观察[J].医学信息,2018,(08):178.[doi:10.3969/j.issn.1006-1959.2018.08.065]
 YANG Kai.Clinical Observation on the Effect of Highly Effective Antiretroviral Therapy on AIDS[J].Medical Information,2018,(11):178.[doi:10.3969/j.issn.1006-1959.2018.08.065]
[8]冯彩云.胺碘酮导致间质性肺病患者的1例分析[J].医学信息,2018,(10):191.[doi:10.3969/j.issn.1006-1959.2018.10.068]
[9]沈孟杰.注射用头孢哌酮钠舒巴坦钠临床应用效果及 不良反应发生情况研究[J].医学信息,2018,(12):131.[doi:10.3969/j.issn.1006-1959.2018.12.040]
 SHEN Meng-jie.Clinical Application and Adverse Reactions of Cefoperazone Sodium and Sulbactam Sodium for Injection[J].Medical Information,2018,(11):131.[doi:10.3969/j.issn.1006-1959.2018.12.040]
[10]王 程,李弘扬,马鹏程.异维A酸少见不良反应及相应对策[J].医学信息,2018,(13):45.[doi:10.3969/j.issn.1006-1959.2018.13.014]
 WANG Cheng,LI Hong-yang,MA Peng-cheng.Uncommon Adverse Reactions of Isotretinoin and Corresponding Countermeasures[J].Medical Information,2018,(11):45.[doi:10.3969/j.issn.1006-1959.2018.13.014]

更新日期/Last Update: 1900-01-01